Evaluation of the effect of Afsantin on COVID 19

Phase 3

Recruiting

• Conditions: Covid-19.; Other coronavirus as the cause of diseases classified elsewhere; U07.1

• Registration Number: IRCT20190415043279N6
• Lead Sponsor: Sanandaj University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Definitive confirmation of Covid 19 based on RT-PCR results
Hospitalized patients
Ventilator independent patients

Exclusion Criteria

Pregnancy
Breastfeeding
Diabetes
Severe renal failure
Metabolic acidosis
Severe respiratory failure
Taking anticoagulants

Study & Design

• Study Type: interventional
• Study Design: Not specified